TC BioPharm (Holdings) plc: key financial figures for fiscal year 2024 (in GBP), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2024)
- -£12.2M
- Total Assets (FY2024)
- £8.3M
- Total Equity (FY2024)
- £3.0M
- Cash Flows from Operating Activities (FY2024)
- -£12.6M
Source: TC BioPharm (Holdings) plc 20-F filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
